Revenue Projection

No one can predict the future, but with the right research and analysis, you can understand the different market scenarios you may face. DeciBio takes a data-driven approach, considering customer demand and preference, product profile, competitive dynamics, regulation, and other market factors to inform your potential revenue scenarios.

Our Experts

David Cavanaugh

David Cavanaugh

Stephane Budel

Miguel Edwards

Schedule a Call

Related Client Results

All Client Results

Pharma & Biotech

Early-Stage Cancer Biomarker Testing and Treatment Landscape Assessment

A top-10 biopharma wanted to assess how the biomarker testing and treatment landscape would change, and the potential impact on the use of their drug, in response to a recent approval of a new competing cancer therapy approved in earlier lines of treatment

Competitive Analysis

Voice-of-Customer Research

Financial Services

PE-Backed Life Sciences Tools Platform Development

A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform

Voice-of-Customer Research

Customer Segmentation

Pricing Strategy

Due Diligence

Competitive Analysis

Financial Services

Investment Diligence into Leading Oncology Diagnostic Provider

A global private equity firm wanted to project the revenues and competitive positioning of a leading oncology diagnostics provider to support a growth capital investment

Voice-of-Customer Research

Competitive Analysis

Revenue Projection

Due Diligence

Synthetic Oligonucleotides Market Sizing

A leader in synthetic oligonucleotide manufacturing wanted to assess the total market size and opportunity

No items found.

Cell Line Market 5-Year Forecast

A large life science tools provider was interested in characterizing the genome engineering and engineered cell line market to identify potential opportunities to participate in the space

Voice-of-Customer Research

Financial Services

CDD on Novel Handheld Diagnostic Device Manufacturer

A global healthcare investment firm wanted to perform a commercial due diligence (CDD) prior to investment in a company producing a novel handheld diagnostic.

Voice-of-Customer Research

KOL Identification

Pricing Strategy

Revenue Projection

Due Diligence

Precision Medicine is evolving at a rapid pace

Discover how we can help